Burlingame, CA · Founded 2025 · Privately Held (backing)
Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms. Inversion Therapeutics is based in Burlingame, CA and was founded in 2025. It was valued at $17 million at its seed round in Aug 2025, the last priced event on record. It has raised $6.9 million across 1 recorded round; the latest was a $6.9 million early-stage round in Jun 2025.
PMV mark · valuation
$17.0M
Oct 2026
Priced at
its seed round
Aug 2025
Total raised
$6.9M
Last round
Early Stage VC
Jun 2025
Cap table — not yet on record
Inversion Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Inversion Therapeutics with a free account
·Watch Inversion Therapeutics: the Monday email on marks, rounds and moves
Where does Inversion Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Inversion Therapeutics's 1 recorded funding rounds.
